Title: What Does the Designated Person(s) Do?
Speakers:
- Annie Lambert, PharmD, BCSCP, Clinical Program Manager, Simplifi+ Compliance Solutions, Wolters Kluwer Health
- Lisa D. Ashworth, BS Pharm, RPh, BCSCP, FACA, Independent Consultant, Ashworth Pharmacy Consultants
Date: June 24, 2025, 12 p.m. CST
Session Description:
This presentation will outline the roles and responsibilities of the Designated Person(s) (DP(s)) in relation to sterile compounding as established in USP 797. It will explore how DP(s) can effectively utilize Standard Operating Procedures (SOPs) and implement strategies to maintain staff engagement and ensure ongoing preparedness for inspections. Through active sharing, observation, and preparation of staff, DP(s) can significantly reduce compliance risks associated with compounding.
Learning Objectives:
· Describe how the DP engages staff and leads the implementation of compounding SOPs.
· Explain the DPs role in managing and sustaining change related to sterile compounding practices.
· Identify monitoring and verification methods used to ensure adherence to SOPs within the pharmacy.
· Discuss examples of quality improvement activities aimed at minimizing compliance risks in sterile compounding.
This webinar is free and accredited for 1 contact hour (0.1 CEUs) of continuing education credit. Register Now >
